期刊文献+

益心解毒方对NOX2亚基和NOX4亚基过表达及小干扰RNA引起的心肌细胞还原型辅酶Ⅱ氧化酶活性变化的机制研究

Mechanism of Yixin Jiedu Formula on the Overexpression of NOX2 and NOX4 and the Myocardial NADPH Ⅱ Oxidase Activity Changes Induced by RNAi
下载PDF
导出
摘要 目的观察益心解毒方含药血清对NOX2、NOX4亚基过表达和小干扰RNA(RNAi)导致的H9C2心肌细胞还原型辅酶Ⅱ(NADPH)氧化酶活性的变化,探讨益心解毒方的作用机制。方法采用正常雄性Sprague-Dawley大鼠16只,构建针对NOX2、NOX4亚基的过表达质粒和RNAi质粒。采用转染试剂瞬时转染H9C2心肌细胞,流式细胞术检测转染率,转染24 h后分组(正常H9C2细胞组、过表达组、H9C2转阴性对照质粒组、RNAi质粒组、益心解毒方高剂量组、益心解毒方中剂量组、益心解毒方低剂量组)给予不同剂量的含药血清干预,24 h后检测NADPH氧化酶活性。结果转染NOX2亚基过表达质粒的各组NADPH氧化酶活性比较,差异有统计学意义(P<0.05)。其中,过表达组、益心解毒方高剂量组、益心解毒方低剂量组与正常H9C2细胞组NADPH氧化酶活性比较,差异有统计学意义(P<0.05);H9C2转阴性对照质粒组、RNAi质粒组、益心解毒方中剂量组与过表达组NADPH氧化酶活性比较,差异有统计学意义(P<0.05);RNAi质粒组、益心解毒方高剂量组、益心解毒方低剂量组与H9C2转阴性对照质粒组NADPH氧化酶活性比较,差异有统计学意义(P<0.05);益心解毒方高剂量组、益心解毒方低剂量组与RNAi质粒组NADPH氧化酶活性比较,差异有统计学意义(P<0.05);益心解毒方中剂量组与益心解毒方高剂量组NADPH氧化酶活性比较,差异有统计学意义(P<0.05);益心解毒方低剂量组与益心解毒方中剂量组NADPH氧化酶活性比较,差异有统计学意义(P<0.05)。转染NOX4亚基过表达质粒的各组NADPH氧化酶活性比较,差异有统计学意义(P<0.05)。其中,过表达组、益心解毒方高剂量组、益心解毒方低剂量组与正常H9C2细胞组NADPH氧化酶活性比较,差异有统计学意义(P<0.05);H9C2转阴性对照质粒组、RNAi质粒组、益心解毒方中剂量组、益心解毒方低剂量组与过表达组NADPH氧化酶活性比较,差异有统计学意义(P<0.05);RNAi质粒组、益心解毒方高剂量组、益心解毒方低剂量组与H9C2转阴性对照质粒组NADPH氧化酶活性比较,差异有统计学意义(P<0.05);益心解毒方高剂量组、益心解毒方低剂量组与RNAi质粒组NADPH氧化酶活性比较,差异有统计学意义(P<0.05);益心解毒方中剂量组与益心解毒方高剂量组NADPH氧化酶活性比较,差异有统计学意义(P<0.05);益心解毒方低剂量组与益心解毒方中剂量组NADPH氧化酶活性比较,差异有统计学意义(P<0.05)。结论 NOX2、NOX4亚基的过表达可以提高NADPH氧化酶活性,而RNAi表达可以沉默NOX2、NOX4亚基,从而降低NADPH氧化酶活性,益心解毒方不会直接影响NADPH氧化酶活性。实验研究表明干预和抑制NOX2、NOX4亚基的NADPH氧化酶活性调控环节,降低心肌活性氧(ROS)水平,保护心肌细胞,改善心功能,可能是益心解毒方发挥药效的重要机制。 Objective To observe the influence of Yixin Jiedu formula on NOX2 and NOX4 overexpression and H9C2 myocardial NADPH Ⅱ oxidase activity changes induced by RNAi and investigate its mechanism. Methods We selected 16 normal male Sprague- Dawley rats and constructed the overexpression plasmids of NOX2 and NOX4 and RNAi plasmids. Transfection reagents were employed to conduct transient transfection of H9C2 myocardial cells, flow cytometry was undertaken to examine transfection efficiency. At 24 hours after transfection, the subjects were divided into normal H9C2 cell group,overexpression group,H9C2 negative- turning control plasmid group, RNAi plasmid group, high- dose Yixin Jiedu formula group,middle- dose Yixin Jiedu formula group and low- dose Yixin Jiedu formula group. All the groups were intervened with different doses of drug serum,and NADPH oxidase activity was detected 24 hours after drug administration. Results The groups in which overexpression plasmids of NOX2 was transfected were significantly different in NADPH oxidase activity( P〈0. 05); overexpression group,high- dose Yixin Jiedu formula group and low- dose Yixin Jiedu formula group were significantly different from normal H9C2 cell group in NADPH oxidase activity( P〈0. 05); H9C2 negative- turning control plasmid group,RNAi plasmid group, middle- dose Yixin Jiedu formula group were significantly different from normal H9C2 cell group in NADPH oxidase activity( P〈0. 05); RNAi plasmid group,high- dose Yixin Jiedu formula group and low- dose Yixin Jiedu formula group were significantly different from H9C2 negative- turning control plasmid group in NADPH oxidase activity( P〈0. 05); high- dose Yixin Jiedu formula group and low- dose Yixin Jiedu formula group were significantly different from RNAi plasmid group in NADPH oxidase activity( P〈0. 05); middle- dose Yixin Jiedu formula group and high- dose Yixin Jiedu formula group were significantly different in NADPH oxidase activity( P〈0. 05); low- dose Yixin Jiedu formula group and middle- dose Yixin Jiedu formula group were significantly different in NADPH oxidase activity( P〈0. 05). The groups in which overexpression plasmids of NOX4 was transfected were significantly different in NADPH oxidase activity( P〈0. 05);overexpression group,high- dose Yixin Jiedu formula group and low- dose Yixin Jiedu formula group were significantly different from normal H9C2 cell group in NADPH oxidase activity( P〈0. 05); H9C2 negative- turning control plasmid group,RNAi plasmid group,middle- dose Yixin Jiedu formula group and low- dose Yixin Jiedu formula group were significantly different from overexpression group in NADPH oxidase activity( P〈0. 05); RNAi plasmid group,high- dose Yixin Jiedu formula group and low- dose Yixin Jiedu formula group were significantly different from H9C2 negative- turning group in NADPH oxidase activity( P〈0. 05); high- dose Yixin Jiedu formula group and low- dose Yixin Jiedu formula group were significantly different from RNAi plasmid group in NADPH oxidase activity( P〈0. 05); middle- dose Yixin Jiedu formula group and high- dose Yixin Jiedu formula group were significantly different in NADPH oxidase activity( P〈0. 05); low- dose Yixin Jiedu formula group and middle- dose Yixin Jiedu formula group were significantly different in NADPH oxidase activity( P〈0. 05). Conclusion The overexpression of NOX2 and NOX4 can significantly improve NADPH oxidase activity,and RNAi expression can silence NOX2 and NOX4,thereby significantly reducing NADPH oxidase activity. Yixin Jiedu formula doesn't directly influence NADPH oxidase activity. The study shows the important mechanism of Yixin Jiedu formula may be that it can intervene and inhibit NADPH oxidase activity of NOX2 and NOX4,reduce the ROS level of myocardial muscle,protect myocardial cell and improve cardiac function.
出处 《中国全科医学》 CAS CSCD 北大核心 2015年第30期3727-3731,共5页 Chinese General Practice
基金 国家自然科学基金资助项目(81102839) 科技部重大新药创制(2012ZX09103-201-011) 北京中医药大学自主选题(2015-JYB-JSMS012)
关键词 益心解毒方 肌细胞 心脏 基因表达 小干扰RNA 氧化还原酶类 Yixin jiedu formula Myocytes cardiac Gene expression RNAi Oxidoreductases
  • 相关文献

参考文献9

二级参考文献43

  • 1侯冬岩,回瑞华,杨梅,唐蕊,刘晓媛,朱永强.金银花中总黄酮的光谱分析及抗氧化性能测定[J].分析试验室,2004,23(11):52-55. 被引量:28
  • 2郭淑贞,王伟,刘涛,刘蕾,童元元,许文玉,于永新,赵慧辉,李宏.小型猪冠心病(心肌缺血)血瘀证模型血液流变学及超声评价[J].中华中医药学刊,2007,25(4):702-705. 被引量:33
  • 3SHI Jing,TIAN Jin-zhou,WANG Yong-yan,et al.The study on biological basis of blood stasis syndrome.China Journal of Traditional Chinese Medicine and Pharmacy,2006,21 (6):363-364.
  • 4Fenster B E,Tsao S,Rockson S G,et al.Endothelial dysfunction: Clinical strategies for treating oxidant stress.Am Heart J, 2003,146(2):216-226.
  • 5Irani K.Oxidant signaling in vascular cell growth,death,and survival:a review of the roles of reactive oxygen species in smooth muscle and endothelial cell mitogenic and apoptotic signaling.Circ Res,2000,87(3):179-183.
  • 6Abel Martin Garrido,Kathy K.Griendling.NADPH Oxidases and Angiotensin Ⅱ Receptor Signaling.Mol Cell Endoerinol,2009,302 (2):148-158.
  • 7Touyz R M,Schiffrin E L.Reactive oxygen species in vascular biology:implications in hypertension.Histochem Cell B iol,2004,122 (4):339-352.
  • 8Kasuga M.Insulin resistance and pancreatic B cell failure.Cli Invest,2006(116):1756-1760.
  • 9Kathy K.Griendling and Garret A.FitzGerald.Oxidative Stress and Cardiovascular Injury:Part I:Basic Mechanisms and In Vivo Monitoring of ROS.Circulation,2003(108): 1912-1916.
  • 10Sheng Jun An,Ryan Boyd,Min Zhu,et al.NADPH oxidase mediates angiotensin Ⅱ-induced endothelin-1 expression in vascular adventitial fibroblasts.Cardiovascular Research,2007(75):702-709.

共引文献39

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部